|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.81 USD | +0.40% |
|
+9.49% | -3.40% |
| May. 03 | GSK plc : Back on track |  |
| May. 03 | Wall Street: optimism ahead of NFP, rates ease | CF |
April 25 (Reuters) - GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies' blockbuster COVID-19 vaccines.
GSK said in the lawsuit that Pfizer and BioNTech's Comirnaty vaccines violate the company's patent rights in mRNA-vaccine innovations developed "more than a decade before" the outbreak of the COVID-19 pandemic. (Reporting by Blake Brittain)
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 2,094 INR | -0.46% | -1.82% | 4.25B | ||
| 92.72 USD | +0.52% | +6.32% | 22.34B | ||
| 27.81 USD | +0.40% | +9.49% | 157B | ||
| 1st Jan change | Capi. | |
|---|---|---|
| -3.40% | 157B | |
| +21.85% | 546B | |
| -4.77% | 359B | |
| +16.97% | 323B | |
| +5.69% | 290B | |
| +13.68% | 234B | |
| +3.65% | 198B | |
| -11.12% | 194B | |
| +8.08% | 167B | |
| +1.72% | 123B |
PFIZER, INC. 
